Achieving cure for early stage pediatric Hodgkin disease with minimal morbidity: Are we there yet?

Pediatric Blood and Cancer

Volumn 46, Issue 2, 2006, Pages 122-126

  Hudson, Melissa M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; HYPOPLASIA; HYPOTHYROIDISM; LAPAROTOMY; LEUKEMOGENESIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MUSCULOSKELETAL DISEASE; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REPRODUCTIVE TOXICITY; SECOND CANCER; SOFT TISSUE DISEASE; SPLENECTOMY; THYROID ADENOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; RECURRENCE; TREATMENT FAILURE;

EID: 30444454788     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20643     Document Type: Note

References (23)

1. Donaldson SS, Whitaker SJ, Plowman PN, et al. Stage I-II pediatric Hodgkin's disease: Long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol 1990;8:1128-1137.
2. Lobo-Sanahuja F, Garcia I, Barrantes JC, et al. Pediatric Hodgkin's disease in Costa Rica: Twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy. Med Pediatr Oncol 1994;22:398-403.
3. Nachman JB, Sposto R, Herzog P, et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002;20:3765-3771.
4. Dorffel W, Luders H, Ruhl U, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Padiatr 2003;215:139-145.
5. Donaldson SS, Hudson MM, Lamborn KR, et al. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 2002;20:3081-3087.
6. Landman-Parker J, Pacquement H, Leblanc T, et al. Localized childhood Hodgkin's disease: Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol 2000;18:1500-1507.
7. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-3232.
8. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 2003;21:4386-4394.
9. Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-3148.
10. Bramswig JH, Heimes U, Heiermann E, et al. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 1990;65:1298-1302.
11. Hobbie WL, Ginsberg JP, Ogle SK, et al. Fertility in males treated for Hodgkins disease with COPP/ABV hybrid. Pediatr Blood Cancer 2005;44:193-196.
12. Hudson MM, Poquette CA, Lee J, et al. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol 1998;16:3592-3600.
13. Donaldson SS, Kaplan HS. Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 1982;66:977-989.
14. Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 1999;17:569-577.
15. Dieckmann K, Potter R, Hofmann J, et al. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. Int J Radiat Oncol Biol Phys 2003;56:644-652.
16. Korholz D, Claviez A, Hasenclever D, et al. The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: Evolution in the tradition of the DAL/GPOH studies. Klin Padiatr 2004;216:150-156.
17. Tebbi CK, Mendenhall N, London WB, et al. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin's disease with doxorubicin, bleomycin, vincristine, and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study. Pediatr Blood Cancer 2005.
18. Desser RK, Golomb HM, Ultmann JE, et al. Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood 1977;49:883-893.
19. Pellegrino B, Terrier-Lacombe MJ, Oberlin O, et al. Lymphocyte- predominant Hodgkin's lymphoma in children: Therapeutic abstention after initial lymph node resection-A Study of the French Society of Pediatric Oncology. J Clin Oncol 2003;21:2948-2952.
20. Murphy SB, Morgan ER, Katzenstein HM, et al. Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents. J Pediatr Hematol Oncol 2003;25:684-687.
21. Polliack A. Late therapy-induced cardiac and pulmonary complications in cured patients with Hodgkin's disease treated with conventional combination chemo-radiotherapy. Leuk Lymphoma 1995;15:7-10.
22. Ortin TT, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 1990;19:873-880.
23. Horning SJ, Hoppe RT, Kaplan HS, et al. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304:1377-1382.